Journal ArticleDOI
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Archie Bleyer,H. Gilbert Welch +1 more
Reads0
Chats0
TLDR
In this paper, the authors examined trends from 1976 through 2008 in the incidence of early-stage breast cancer (ductal carcinoma in situ and localized disease) and late-stage cancer (regional and distant disease) among women 40 years of age or older.Abstract:
BackgroundTo reduce mortality, screening must detect life-threatening disease at an earlier, more curable stage. Effective cancer-screening programs therefore both increase the incidence of cancer detected at an early stage and decrease the incidence of cancer presenting at a late stage. MethodsWe used Surveillance, Epidemiology, and End Results data to examine trends from 1976 through 2008 in the incidence of early-stage breast cancer (ductal carcinoma in situ and localized disease) and late-stage breast cancer (regional and distant disease) among women 40 years of age or older. ResultsThe introduction of screening mammography in the United States has been associated with a doubling in the number of cases of early-stage breast cancer that are detected each year, from 112 to 234 cases per 100,000 women — an absolute increase of 122 cases per 100,000 women. Concomitantly, the rate at which women present with late-stage cancer has decreased by 8%, from 102 to 94 cases per 100,000 women — an absolute decreas...read more
Citations
More filters
Journal ArticleDOI
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society
Kevin C. Oeffinger,Elizabeth T. H. Fontham,Ruth Etzioni,Abbe Herzig,James S. Michaelson,Ya Chen Tina Shih,Louise C. Walter,Timothy R. Church,Christopher R. Flowers,Samuel J. LaMonte,Andrew M.D. Wolf,Carol DeSantis,Joannie Lortet-Tieulent,Kimberly S. Andrews,Deana Manassaram-Baptiste,Debbie Saslow,Robert A. Smith,Otis W. Brawley,Richard C. Wender +18 more
TL;DR: The updated ACS guidelines for breast cancer screening for women at average risk of breast cancer provide evidence-based recommendations and should be considered by physicians and women in discussions about breast cancer Screening.
Journal ArticleDOI
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Edward F. Patz,Paul F. Pinsky,Constantine Gatsonis,Jo Rean D. Sicks,Barnett S. Kramer,Martin C. Tammemägi,Caroline Chiles,William C. Black,Denise R. Aberle +8 more
TL;DR: More than 18% of all lung cancers detected by LDCT in the NLST seem to be indolent, and overdiagnosis should be considered when describing the risks of LDCT screening for lung cancer.
Journal ArticleDOI
Benefits and Harms of Breast Cancer Screening: A Systematic Review
Evan R. Myers,Patricia G. Moorman,Jennifer M Gierisch,Laura J. Havrilesky,Laura J. Havrilesky,Lars J. Grimm,Sujata V. Ghate,Brittany A. Davidson,Ranee Chatterjee Mongtomery,Matthew J Crowley,Matthew J Crowley,Matthew J Crowley,Douglas C McCrory,Douglas C McCrory,Douglas C McCrory,Amy S Kendrick,Gillian D Sanders,Gillian D Sanders +17 more
TL;DR: Evidence for the relationship between screening and life expectancy and quality-adjusted life expectancy was low in quality and uncertainty remains about the magnitude of associated mortality reduction in the entire US population, among women 40 to 49 years, and with annual screening compared with biennial screening.
Journal ArticleDOI
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness
TL;DR: Although the rate of detection of large tumors fell after the introduction of screening mammography, the more favorable size distribution was primarily the result of the additional detection of small tumors.
Journal ArticleDOI
Addressing overdiagnosis and overtreatment in cancer: a prescription for change
Laura J. Esserman,Ian M. Thompson,Brian J. Reid,Peter S. Nelson,David F. Ransohoff,H. Gilbert Welch,Shelley Hwang,Donald A. Berry,Kenneth W. Kinzler,William C. Black,Mina J. Bissell,Howard L. Parnes,Sudhir Srivastava +12 more
TL;DR: Changing the terminology for some of the lesions currently referred to as cancer will allow physicians to shift medicolegal notions and perceived risk to reflect the evolving understanding of biology, be more judicious about when a biopsy should be done, and organise studies and registries that offer less invasive approaches for indolent disease.
Related Papers (5)
Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
Ned Calonge,Diana B. Petitti,Thomas G. DeWitt,Allen J. Dietrich,Kimberly D. Gregory,David C. Grossman,George Isham,Michael L. LeFevre,Rosanne M. Leipzig,Lucy N. Marion,Bernadette Mazurek Melnyk,Virginia A. Moyer,Judith K. Ockene,George F. Sawaya,J. Sanford Schwartz,Timothy J Wilt,US Preventive Serv Task Force +16 more
Screening for breast cancer: U.S. preventive services task force recommendation statement
Ned Calonge,Ned Calonge,Diana B. Petitti,Diana B. Petitti,Thomas G. DeWitt,Thomas G. DeWitt,Allen J. Dietrich,Allen J. Dietrich,Kimberly D. Gregory,Kimberly D. Gregory,David C. Grossman,David C. Grossman,George Isham,George Isham,Michael L. LeFevre,Michael L. LeFevre,Rosanne M. Leipzig,Rosanne M. Leipzig,Lucy N. Marion,Lucy N. Marion,Bernadette Mazurek Melnyk,Bernadette Mazurek Melnyk,Virginia A. Moyer,Virginia A. Moyer,Judith K. Ockene,Judith K. Ockene,George F. Sawaya,George F. Sawaya,J. Sanford Schwartz,J. Sanford Schwartz,Timothy J Wilt,Timothy J Wilt +31 more